Register
Login:
Share:
Email Facebook Twitter




Sareum Share Chat (SAR)



Share Price: 0.83Bid: 0.82Ask: 0.84Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.02Spread as %: 2.44%Open: 0.845High: 0.00Low: 0.00Yesterday’s Close: 0.83


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


diggit1gold
Posts: 248
Off Topic
Opinion:No Opinion
Price:0.83
I read an article
Mon 22:54
in a Bio magazine ( possibly called Drugs and Deals ) from 2014 where Tim stated that he honestly believed that SAREUM would succumb to buyout by a major Pharma as he fully expected milestone payments at some point in the not too distant future to exceed SAR,s MCAP. Can't be bad.
 
mangio61
Posts: 1,964
Off Topic
Opinion:No Opinion
Price:0.83
RE: I believe imho
Mon 21:50
well I have targeted to retire by september 2016 :-) ..... who knows X
Thoth2
Posts: 676
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.83
View Thread (2)
I believe imho
Mon 21:48
Azn will take a licence for use with its wee1 inhibitor. Whether this later in the year. Over the summer. Or before next weekends azn pipeline presentations at ASCO. But imho it's coming. Sooner than many expected. DYOR imho etc
mangio61
Posts: 1,964
Off Topic
Opinion:No Opinion
Price:0.83
RE: derrrrr....no
Mon 21:21
i think you know the answer.... but in case you do not it is not a problem as you will see the other side of the coin soon. Recently I heard the ALL-Cons was praying all GODS of any faith to get his cheap entry.... are you in the same boat? ATB
mangio61
Posts: 1,964
Off Topic
Opinion:No Opinion
Price:0.83
Thought2
Mon 21:15
How was the weekend? long and busy I suppose... where's the e-mail you were going to send? X
Thoth2
Posts: 676
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.83
RE: Journal of Medicinal Chemisty
Mon 20:53
num4- you have mail....
Thoth2
Posts: 676
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.83
RE: Wee1 & Astrazeneca
Mon 20:49
and surely a scientist working on both compounds would be dealing with CRUK or the ICR, rather than with sixthelementcapital. game on shortly buddies...
Num4
Posts: 911
Research
Opinion:Strong Buy
Price:0.83
Journal of Medicinal Chemisty
Mon 20:48
New publication: http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01938

Few additional names under the Sareum banner also, one member worked for them many years ago Philip M. Leonard.
Thoth2
Posts: 676
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.83
Wee1 & Astrazeneca
Mon 20:45
https://pharmaceuticalintelligence.com/2016/01/31/astrazenecas-wee1-protein-inhibitor-azd1775-shows-success-against-tumors-with-a-setd2-mutation/

One of AZN DDR dugs is a wee inhibitor (in article). It is very effective when combined with a chk1 inhibitor (see diagram near bottom of article).

only problem is AZN doesnt have an active chk1 program any more. and we are the ones in the clinic available to licence. buy hey ho so much conjecture. surely there would be some literature or something on the two together. ......
bonker99
Posts: 24,034
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.83
RE: sub 1p
Mon 20:29
Don't sweat it mate - they're gonna do what they're gonna do and it'll go where it's gonna go ...

If it ain't at 80 then they'll turn it at low 60s but the targets are just the same - 2p, 3.2p and 5.2p, for end of trial/August 2017 ...




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.